Medicare Enrolled
Dr. Azim Lalani, MD
Family Medicine · Bradenton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lalani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lalani? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lalani
Dr. Azim Lalani is a family medicine in Bradenton, FL, with 18 years in practice. Based on federal Medicare data, Dr. Lalani performed 13,596 Medicare services across 4,862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lalani received a total of $12,589 from 57 pharmaceutical and/or device companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lalani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 1% volume in FL$ $12,589 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,596
Medicare services
Top 1% in FL for family medicine
4,862
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~755 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity | 2,294 | $83 | $185 |
| Office visit, established patient (30-39 min) | 2,269 | $93 | $215 |
| Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | 1,132 | $24 | $64 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 901 | $120 | $250 |
| Denosumab injection (Prolia/Xgeva) | 900 | $19 | $35 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 745 | $11 | $40 |
| Hospital follow-up visit, high complexity | 447 | $94 | $213 |
| Office visit, established patient, complex (40-54 min) | 338 | $131 | $291 |
| Home visit, established patient, moderate complexity | 301 | $100 | $262 |
| Telephone medical discussion with physician, 11-20 minutes | 295 | $66 | $180 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 285 | $24 | $68 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 251 | $143 | $338 |
| Annual alcohol misuse screening, 5 to 15 minutes | 243 | $18 | $36 |
| Advance care planning consultation, first 30 min | 242 | $79 | $166 |
| Annual depression screening | 235 | $18 | $36 |
| Drug injection, under skin or into muscle | 225 | $11 | $75 |
| Annual wellness visit, follow-up | 222 | $125 | $233 |
| Hospital follow-up visit, moderate complexity | 160 | $62 | $147 |
| Destruction of precancerous skin growths, 2-14 | 156 | $5 | $50 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 123 | $37 | $92 |
| Initial hospital admission, high complexity | 120 | $135 | $413 |
| Telephone medical discussion with physician, 5-10 minutes | 118 | $41 | $100 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 112 | $1 | $10 |
| Ceftriaxone antibiotic injection | 103 | $0 | $5 |
| Chronic care management, first 20 min/month | 96 | $48 | $85 |
| Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 94 | $143 | $362 |
| Flu vaccine administration | 93 | $30 | $75 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 92 | $22 | $60 |
| Hospital discharge management, 30+ min | 90 | $90 | $218 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 82 | $206 | $500 |
| Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualif | 82 | $24 | $63 |
| Electrocardiogram (EKG), 12-lead | 78 | $11 | $34 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 64 | $22 | $57 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 50 | $40 | $108 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 50 | $81 | $218 |
| Injection, methylprednisolone acetate, 40 mg | 49 | $6 | $35 |
| Transitional care management services for problem of high complexity | 45 | $202 | $462 |
| Destruction of precancerous skin growth, 1 | 44 | $51 | $150 |
| Urinalysis, manual | 40 | $3 | $15 |
| COVID-19 vaccine administration | 37 | $40 | $80 |
| COVID-19 vaccine (Pfizer bivalent) | 37 | $128 | $262 |
| Echocardiogram, transthoracic | 31 | $142 | $449 |
| Office visit, established patient (20-29 min) | 28 | $63 | $146 |
| Joint injection, major joint | 23 | $49 | $129 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $99 | $250 |
| New patient office visit (45-59 min) | 19 | $131 | $331 |
| New patient office visit, complex (60-74 min) | 19 | $164 | $418 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 19 | $25 | $52 |
| Ultrasound of both sides of head and neck blood flow | 18 | $145 | $398 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 18 | $32 | $83 |
| Injection, methylprednisolone acetate, 80 mg | 17 | $9 | $35 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $144 | $387 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 15 | $55 | $146 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $157 | $334 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
10.9% medium
88.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,589
Total received (2018-2024)
Avg $1,798/year across 7 years
Top 3% in FL for family medicine
57
Companies
688
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,589 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,289
2023$1,621
2022$1,840
2021$1,700
2020$1,627
2019$2,182
2018$2,328
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,987
GlaxoSmithKline, LLC.
$1,016
Novo Nordisk Inc
$990
PFIZER INC.
$878
Amgen Inc.
$829
Lilly USA, LLC
$737
Janssen Pharmaceuticals, Inc
$463
Boehringer Ingelheim Pharmaceuticals, Inc.
$453
Merck Sharp & Dohme Corporation
$436
Otsuka America Pharmaceutical, Inc.
$435
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$355
ABBVIE INC.
$313
Neuronetics, Inc.
$291
SANOFI-AVENTIS U.S. LLC
$226
Astellas Pharma US Inc
$185
Novartis Pharmaceuticals Corporation
$182
AbbVie Inc.
$179
Teva Pharmaceuticals USA, Inc.
$171
Synergy Pharmaceuticals Inc
$169
Sunovion Pharmaceuticals Inc.
$140
Bayer HealthCare Pharmaceuticals Inc.
$138
Allergan Inc.
$135
Lundbeck LLC
$130
Eisai Inc.
$119
Amarin Pharma Inc.
$115
Abbott Laboratories
$105
Kowa Pharmaceuticals America, Inc.
$104
Actelion Pharmaceuticals US, Inc.
$98
Exact Sciences Corporation
$98
Mannkind Corporation
$77
Boston Scientific Corporation
$77
Corium, LLC
$73
Merck Sharp & Dohme LLC
$72
Mylan Specialty L.P.
$61
NESTLE HEALTHCARE NUTRITION INC.
$60
Radius Health, Inc.
$59
Allergan, Inc.
$59
Biogen, Inc.
$57
Paratek Pharmaceuticals, Inc.
$54
Inari Medical, Inc.
$42
Biohaven Pharmaceuticals, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$39
Biohaven Pharmaceutical Holding Company Ltd.
$38
Shield Therapeutics Inc
$30
Circassia Pharmaceuticals Inc
$30
ABIOMED
$28
Nevro Corp.
$25
Scilex Pharmaceuticals Inc.
$24
Phadia US Inc.
$23
VIVUS, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
Xeris Pharmaceuticals, Inc.
$18
Phathom Pharmaceuticals, Inc.
$18
Nestle HealthCare Nutrition Inc.
$17
SCILEX PHARMACEUTICALS INC.
$17
Horizon Therapeutics plc
$16
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADLARITY · ADUHELM · ADVAIR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · Adlarity · Aimovig · Austedo XR · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BOTOX · BOTOX THERAPEUTIC · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYDUREON · CHANTIX · CREON · Cologuard Collection Kit · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · EVUSHELD · FARXIGA · FIASP · FLOWTRIEVER CATHETER · FLUMIST QUADRIVALENT · FREESTYLE LIBRE 2 · GVOKE PFS · INVOKANA · ImmunoCAP · Impella · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Myrbetriq · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NURTEC ODT · NUZYRA · OFEV · OPSUMIT MACITENTAN · Omnia · Otezla · Ozempic · PANCREAZE · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · REXULTI · RYBELSUS · Repatha · Rybelsus · S · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tresiba · Trulance · Tymlos · UBRELVY · VERQUVO · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · XARELTO · XIFAXAN · XOSPATA · Xultophy 100/3.6 · Yupelri · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in FL.
Equivalent to $93 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
591
Per 100K population
142.1
County median income
$75,792
Nearest hospital
HCA FLORIDA BLAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lalani is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 3%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lalani experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Lalani performed 2,294 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lalani receive payments from pharmaceutical companies?
Yes. Dr. Lalani received a total of $12,589 from 57 companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lalani's costs compare to other family medicines in Bradenton?
Dr. Lalani's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lalani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Bradenton
Browse family medicines in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology